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Original repOrt
We report the first study of antigen and phenotype prevalence 
within various blood group systems in the Iranian general 
population. In this retrospective study, samples from 3475 
individuals referred to the Immunohematology Reference 
Laboratory of the Iranian Blood Transfusion Organization, 
Tehran, Iran, for paternity testing from 1998 to 2008 were 
additionally tested for red blood cell (RBC) antigens in the Rh, 
Kell, Kidd, Duffy, MNS, Lutheran, P1PK, and Xg blood group 
systems. The antigen testing was performed by the tube method, 
and the phenotype prevalences were expressed as percentages. Of 
3475 (1857 male and 1618 female) blood samples, 1268 samples 
were typed as group O (36.49%), 1115 as group A (32.09%), 823 
as group B (23.68%), and 269 as group AB (7.74%). In our sample 
population, 3152 (90.71%) samples were D+ and 323 (9.29%) 
were D–. Analysis of Rh antigen typing results showed e (3359; 
96.66%) to be most prevalent in the Iranian population, followed 
by D (3152; 90.71%), C (2677; 77.04%), c (2557; 73.58%), and E 
(1059; 30.47%). In the Kell blood group system, 3293 (94.76%) 
samples were typed as K–k+. For the Kidd and Duffy blood group 
systems, the following were the most common phenotypes: 
Jk(a+b+) (1703; 49%), Jk(a+b–) (1006; 28.95%), Fy(a+b+) (1495; 
43.02%), and Fy(a+b–) (1005; 28.92%). In the MNS blood group 
system, the following were the most common phenotypes: M+N+ 
(1668; 48%), M+N– (1310; 37.70%), S+s+ (1564; 45%), and S–s+ 
(1392; 40.06%). In the Lutheran and P1PK blood group systems, 
Lu(a–b+) and P1+ phenotypes were observed in 3292 (94.73%) 
and 1966 (56.58%) samples, respectively. The Xg antigen was 
present in 1953 (56.20%) samples versus 1522 (43.80%) samples 
identified as Xg(a–). Knowledge of the prevalence of RBC antigen 
phenotypes in a population can be useful in databank creation 
for providing antigen-negative compatible blood to patients 
with multiple alloantibodies. Immunohematology 2016;32: 
135–139.
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The nine major blood group systems include ABO, Rh, Kell, 
Kidd, Duffy, MNS, P1PK, Lewis, and Lutheran.1,2 Identifying 
blood group antigens is very important in blood transfusion 
and organ transplantation to minimize major transfusion 
reactions.3,4 Determining the prevalence of red blood cell 
(RBC) antigens of various blood groups in first-time voluntary 
blood donors would help us obtain insight into blood group 
distribution in a geographic population. This information 
can also help us lay the foundation for starting a databank of 
antigen-negative blood, which would aid in the prevention of 
transfusion reactions in alloimmunized patients.5 There are 
some studies limited to ABO and Rh blood groups,6–10 but other 
than one older study of blood group distribution,11 no current 
data are available on RBC antigens and phenotype prevalence 
in Iran. The present study is the first comprehensive report 
of the prevalence of various RBC antigens and phenotypes of 
various blood groups in the Iranian general population.
Materials and Methods
This retrospective study was carried out using the data 
from 3475 individuals referred for paternity testing 
during a period of 10 years (from 1998 to 2008) to the 
Immunohematology Reference Laboratory (IRL) of the 
Iranian Blood Transfusion Organization (IBTO), Tehran, Iran, 
to derive information on the population prevalence of antigens 
and phenotypes in ABO, Rh, and seven other major blood 
group systems.
Ethical Considerations
This study was approved by the ethics committee of IBTO 
and its health services. Individuals were asked to sign an 
informed consent form before blood samples were obtained. 
All the terms of the Helsinki Declaration were met, and the 
personal information remained anonymous.
Sample Size
The sample size included all blood samples from 
individuals referred to the national forensic laboratory in 
Tehran, Iran, and the IRL of IBTO. During these 10 years, 
blood samples were collected and tested independently in two 
centers.
Blood Samples
TesTing for ABo And rh AnTigens
Six milliliters of peripheral blood was drawn from each 
person into a vial containing ethylenediaminetetraacetic acid 
(EDTA) anticoagulant. Blood samples were collected under 
aseptic conditions from an anticubital vein for determination 
of blood group antigens. Initial ABO blood grouping was 
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determined by the tube method using commercially prepared 
antisera provided by Iranian Blood Research and Fractionation 
[IBRF], Tehran, Iran. The presence of D was determined 
serologically using reagents from IBRF. Weak-D testing was 
performed on samples initially tested as D–. Repeat ABO 
and D testing for blood group confirmation was performed 
by the conventional tube method as per our standard 
operating procedure using monoclonal reagents from different 
commercial companies: anti-A (Bio-Rad, Munich, Germany), 
anti-B (Bio-Rad), and anti-D (CE-Immumodiagnostika, 
Heidelberg, Germany). Testing for the presence of the 
weak-D phenotype was done on all samples typed as D– as 
per manufacturer’s instructions. The tube method using a 
2–5 percent RBC suspension and monoclonal Rh antisera 
(anti-C, anti-c, anti-E, and anti-e, Diamed AG, Cressier sur 
Morat, Switzerland) as per the manufacturer’s instructions 
was performed for the common Rh antigens (C, E, c, e). A 
reaction range of 1+ to 4+ agglutination indicated the presence 
of the corresponding antigen. The absence of agglutination 
was confirmed macroscopically per the manufacturer’s 
instructions indicating the antigen’s absence.
TesTing for Kell, Kidd, duffy, Mnss, luTherAn, P1, And Xg 
AnTigens
Cells with either the presence or absence of the antigens 
to be tested were selected from an in-house screening cell 
panel that was validated with commercial panel cells (Diacell, 
Diamed AG). These cells were used as positive and negative 
controls to ensure expected reactivity of antisera to be used in 
the testing.
inTerPreTATion of TuBe TesTing resulTs: 
Positive: Various-sized clumps of RBCs on the bottom 
of the tube, graded from 1+ to 4+, indicated the presence of the 
corresponding antigen.
Negative: A smooth RBC suspension after re-suspension 
of cells on the bottom of the tube indicated the absence of the 
corresponding antigen.
Statistical Analysis
RBC antigen and phenotype prevalence within the various 
blood group systems was calculated by totaling the number 
of individuals positive for a particular antigen or phenotype 
divided by the total number of individuals screened. Results 
are expressed as a percentage.
Results
The prevalence of different blood group antigens and 
phenotypes in a total of 3475 (1857 male and 1618 female) 
individual samples was compared.
ABO and Rh Blood Group Systems
The breakdown of results for ABO blood grouping was 
1268 (36.49%) typed as group O followed by 1115 (32.09%) as 
group A, 823 (23.68%) as group B, and 269 (7.74%) as group 
AB. D phenotype prevalence analysis showed 3152 (90.71%) 
D+ individuals and 323 (9.27%) D– individuals. In total, 
among D+ individuals, group O (1148; 33.06%) was found 
to be most prevalent followed by groups A (1014; 29.19%), B 
(743; 21.41%), and AB (247; 7.11%). Among D– individuals, 
blood groups O (128; 3.7%) and A (107; 3.10%) were the 
most common, followed by groups B (75; 2.17%) and AB (13; 
0.62%). Testing for Rh antigens found Rh5(e) (3359; 96.66%) 
to be most prevalent of the common Rh antigens in this Iranian 
population, followed by Rh1(D) (3152; 90.70%), Rh2(C) (2677; 
77.04%), Rh4(c) (2557; 73.58%), and Rh3(E) (1059; 30.47%). 
Nine probable Rh phenotype combinations were found to be 
present in our D+ population; the most common phenotype 
was DCe/dce (R1r; 873; 27.70%) (Tables 1 and 2).
Other Blood Group Systems
In the Kell blood group system, 3293 (94.76%) samples 
were typed as K–k+. The Kp(a+b–) phenotype was rarely 
found. In the Kidd and Duffy blood group systems, Jk(a+b+) 
(1670; 48.06%) and Fy(a+b+) (1466; 42.19%) were the most 
common phenotypes observed. Jk(a–b–) and Fy(a–b–) were 
found as rare phenotypes in the Kidd and Duffy blood group 
systems, respectively. M+N+ (1660; 47.77%) and S+s+ (1569; 
45.15%) were the most common phenotypes observed in the 
E. Shahverdi et al.
Table 1. Prevalence of D+ phenotypes in the Iranian study 
population (N = 3152)
Phenotype
Antigens present Fisher-Race Modified Weiner Prevalence (%)
D Cc e DCe/dce R1r 27.70
D C e DCe/DCe R1R1 22.38
D Cc Ee DCe/DcE R1R2 14.59
D c Ee DcE/dce R2r 10.35
D c E DcE/DcE R2R2 2.30
D c e Dce/dce R0r 1.78
D C Ee DCE/DCe RzR1 0.08
D Cc E DCE/DcE RzR2 0.01
D C E DCE/DCE RzRz 0.008
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MNS blood group system. In the Lutheran and P1PK blood 
group systems, Lu(a–b+) and P1+ phenotypes were observed 
in 3292 (94.73%) and 1966 (56.58%) samples, respectively. 
The rare phenotype Lu(a–b–) was observed in none (0%) of 
the samples. The Xg antigen was identified in 1953 samples 
(56.20%), versus 1522 (43.80%) samples that typed as Xg(a–) 
(Table 3).
Discussion
In our study, blood group O was the most prevalent, 
followed by groups A, B, and AB. According to some studies, 
in the United States, group O is the most prevalent, followed by 
groups A, B, and AB.12 Klein and Anstee13 showed that the most 
common blood groups in Australians were O and A. These 
results are in line with our findings. According to a previous 
Iranian study, blood group O was the most common.14 The 
prevalence is different between that study and ours (41% vs. 
36%). In contrast, in some other studies of populations in other 
countries,3,15–18 blood group B was most prevalent. According 
to Tomilin et al.,19 blood group A was the most prevalent group 
in the Russian Federation.
In our study, the targeted population showed D– 
prevalence of 9 percent, as compared with 17 percent in 
Britain and 4.29 percent in India.20,21 This result suggests that 
the expected rate of Rh isoimmunization would be lower in our 
population than that encountered in the British population. 
Studies have reported that in the United States, 85 percent of 
the population were found to be D+.22 The prevalence of D– 
individuals varies from 20 percent to 40 percent in Basque 
populations to 0 percent to 1 percent in Japanese, Chinese, 
Burmese, Melanesian, Mauri, American Indian, and Eskimo 
populations.3
The worldwide prevalence of D differs between ethnic 
groups—from 85 percent in white populations to 92 percent 
in black populations.23,24 In the present study, we found the 
prevalence of D to be 91 percent. 
We report for the first time the prevalence of other common 
antigens in the Rh system, including C, c, E, and e, in a general 
Iranian population. We found e to be the most prevalent Rh 
antigen in this population. DCe/dce (R1r) was the most common 
phenotype in the D+ population versus dce/dce (rr) in that of the 
D–. In previous studies on Thai and Chinese individuals, CDe/
CDe (R1R1) has been reported to be of the highest prevalence.25 
Nanu and Thapliyal also found DCe/DCe (R1R1) to be the most 
common phenotype in that population.26 The prevalence of cde/
cde (rr) varies among different ethnic groups. It was reported in 
35 percent of white individuals, 26 percent of black individuals, 
and in only 3 percent of individuals of Asian descent.27–30
Table 2. Prevalence of D– phenotypes in the Iranian study 
population (N = 323)
Phenotype
Antigens present Fisher-Race (assumed) Modified Weiner Prevalence (%)
c e dce/dce rr 9.59
Cc e dCe/dce r′r 1.95
c Ee dcE/dce r″r 0.45
Cc Ee dCe/dcE r′r″ 0.05
C e dCe/dCe r′r′ 0.04
c E dcE/dcE r″r″ 0.001
C Ee dCE/dCe ryr′ Rare
CE dCE/dCE ryry Rare
Cc E dCE/dcE ryr″ Rare
Cc Ee dCE/dce ryr Rare
Table 3. Prevalence of phenotypes in various blood group systems 
in the Iranian study population (N = 3475)
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In the Kell system, the most common phenotype in our 
population was found to be K–k+ (95%), which is found in 100 
percent of peoples from Southeast Asia.27 The prevalence of 
K+k– in this study was 0.2 percent. None of the individuals 
of the Thakral et al. study5 were found to be K+k–. The rarest 
phenotype in our study was Kp(a+b–), whereas Kp(a+b+) 
was found to be rare in the Thakral et al. study population.5 
This shows that a rare phenotype in a certain population 
does not necessarily imply rarity of that phenotype in another 
population.
In the Duffy system, Fy(a+b+) and Fy(a–b–) were the most 
common and the rarest phenotypes, respectively. According 
to Agarwal et al.,15 Fy(a–b–) was rare in Indian and white 
populations, although it was common in a black population. In 
virtually all Indian studies, Fy(a+b+) was the most common 
phenotype in the white population.15 Plasmodium vivax is 
endemic to India, and therefore we expect India to have a 
high prevalence of the Fy(a–b–) phenotype because the Duffy 
antigen has been proposed to be the receptor for entry of P. 
vivax into red blood cells.31 Lack of this phenotype in studies 
from India could be attributable to fewer P. vivax infections. In 
Iran, thanks to preventive measures and treatment protocols, 
malaria has been eradicated, and this may account for the low 
prevalence of the Fy(a–b–) phenotype in our population.
Jk(a+b+) was the most common Kidd phenotype in our 
study. Nathalang et al.27 reported similar findings in Asian and 
Thai populations. Moreover, Jk(a–b–) has rarely been found.
In our study, the M+N+ phenotype was the most common 
in the MNS blood group system. In the Nanu and Thapliyal 
study, the M+N– phenotype was reported to be the most 
common.26
S+s+ was the most common phenotype in our study. In 
other studies, S–s+ has been reported as the most common 
phenotype.5,15 Further, the M+N+S+s+ phenotype was 
reported to be the most common by Nanu and Thapliyal, 
as well as in people of European descent and in African 
Americans.26,32,33 In our population study, M+N+S+s+ was 
found to be the most common phenotype. It is possible that 
in areas where heterozygous phenotypes are most prominent, 
less alloimmunization occurs. In these areas, the value of a 
donor database might be in question.
In the Lutheran system, Lu(a–b+) was the most common 
phenotype found in our study, which is true for most of the 
populations around the world.15 In our study, there also was no 
one with the Lu(a–b–) phenotype. Lu(a–b–) was reported as a 
very rare phenotype in the study by Thakral et al.5
In the P1PK system, P1+ was the most common 
phenotype in our study. Musa et al.34 demonstrated that 
Malays and Chinese populations had high prevalence of the 
P1– phenotype, whereas the Indian population had higher 
prevalence of P1+. A lower prevalence of the P1– phenotype 
was reported among Thai individuals.35
In our study, the Xg(a+) phenotype was found as the most 
common phenotype in the Xg blood system. The distribution 
of the Xg antigen in our sample population is comparable with 
that reported in the Daniels study.36
Conclusions
We reported on the distribution of various blood group 
antigens and phenotypes among a general Iranian population. 
The study has a vital impact on the management of blood 
bank and transfusion services in this area. Knowledge of 
blood group antigen distribution is also important for clinical 
studies, for worldwide reliable geographical information, and 
for forensic research in various populations.
References
 1. Daniels G, Castilho L, Flegel W, Fletcher A, Garratty G, Levene 
C, et al. International Society of Blood Transfusion Committee 
on Terminology for Red Blood Cell Surface Antigens: Macao 
report. Vox Sang 2009;96:153–6.
 2. Smart E, Armstrong B. Blood group systems. ISBT Sci Ser 
2008;3:68–92.
 3. Khattak ID, Khan TM, Khan P, Shah S, Khattak ST, Ali A. 
Frequency of ABO and Rhesus blood groups in District Swat, 
Pakistan. J Ayub Med Coll Abbottabad 2008;20:127–9.
 4. Khurshid B, Naz M, Hassan M, Mabood S. Frequency of ABO 
and Rh (D) blood groups in district Swabi NWFP (Pakistan). J 
Sc Tech Univ Peshawar 1992;16:5–6.
 5. Thakral B, Saluja K, Sharma RR, Marwaha N. Phenotype 
frequencies of blood group systems (Rh, Kell, Kidd, Duffy, 
MNS, P, Lewis, and Lutheran) in north Indian blood donors. 
Transfus Apher Sci 2010;43:17–22.
 6. Pourfathollah A, Oody A, Honarkaran N. Geographical 
distribution of ABO and Rh (D) blood groups among Iranian 
blood donors in the year 1361 (1982) as compared with that 
of the year 1380 (2001). Sci J Iran Blood Transfus Organ. 
2004;1:11–7.
 7. Boskabady M, Shademan A, Ghamami G, Mazloom R. 
Distribution of blood groups among population in the city of 
Mashhad (North East of Iran). Pak J Med Sci 2005;21:194–8.
 8. Paridar M, Shoushtari MM, Kiani B, Nori B, Shahjahani M, 
Khosravi A, et al. Distribution of ABO blood groups and rhesus 
factor in a large scale study of different cities and ethnicities 
in Khuzestan province, Iran. Egyptian J Med Hum Genet 
2016;17:105–9.
 9. Ghobadian Z, Sayemiri K, Zeinali M, Sajjadi SM. Distribution of 
ABO and Rh blood groups in a major ethnic group of the West 
Iran, the Kurdish population. Asian J Med Sci 2014;5:26–9.
 10. Nojavan M, Shamsasenjan K, Movassaghpour AA, 
Akbarzadehlaleh P, Torabi SE, Ghojazadeh M. Allelic 
E. Shahverdi et al.
IMMUNOHEMATOLOGY, Volume 32, Number 4, 2016 139
Blood groups in Iran
prevalence of ABO blood group genes in Iranian Azari 
population. BioImpacts 2012;2:207.
 11. Farhud D, Eftekhari A. Blood groups distribution in Iran. 
Iranian J Public Health 1994;23:1–10.
 12. Frances T. Blood groups (ABO groups). Common laboratory 
and diagnostic tests. 3rd ed. Philadelphia, PA: Lippincott, 
2002:19–5.
 13. Klein HG, Anstee DL, eds. ABO, H, LE, P1PK, GLOB, I and 
FORS blood group systems. In: Mollison’s blood transfusion 
in clinical medicine. 12th ed. Oxford, UK: John Wiley & Sons, 
2014:119.
 14. Marzban M, Kamali M, Hosseinbasi T. Blood groups of 
the people of Ahwaz, Iran. Anthropologischer Anzeiger 
1988;46:83–9.
 15. Agarwal N, Thapliyal RM, Chatterjee K. Blood group 
phenotype frequencies in blood donors from a tertiary care 
hospital in north India. Blood Res 2013;48:51–4.
 16. Rahman M, Lodhi Y. Frequency of ABO and Rhesus blood 
groups in blood donors in Punjab. Pak J Med Sci 2004;20: 
315–8.
 17. Khan MS, Subhan F, Tahir F, Kazi BM, Dil AS, Sultan S, et 
al. Prevalence of blood groups and Rh factor in Bannu region 
NWFP (Pakistan). Pak J Med Res 2004;43:8–10.
 18. Hammed A, Hussain W, Ahmed J, Rabbi F, Qureshi J. 
Prevalence of phenotypes and genes of ABO and rhesus 
(Rh) blood groups in Faisalabad, Pakistan. Pak J Biol Sci 
2002;5:722–4.
 19. Tomilin V, Gurtovaia S. [The incidence of finding ABO system 
antigens in the population of the Russian Federation]. Sud Med 
Ekspert 1999;42:16–8.
 20. Chandra T, Gupta A. Frequency of ABO and rhesus blood 
groups in blood donors. Asian J Transfus Sci 2012;6:52.
 21. Klein HG, Anstee DL, eds. The Rh blood group system 
(including LW and RHAG). In: Blood transfusion in clinical 
medicine. 12th ed. Oxford, UK: John Wiley & Sons, 2014:170.
 22. Bashwari L, Al-Mulhim AA, Ahmad MS, Ahmed MA. 
Frequency of ABO blood groups in the Eastern region of Saudi 
Arabia. Saudi Med J 2001;22:1008–12.
 23. Banks RE, Stanley AJ, Cairns DA, Barrett JH, Clarke P, 
Thompson D, et al. Influences of blood sample processing 
on low–molecular-weight proteome identified by surface-
enhanced laser desorption/ionization mass spectrometry. Clin 
Chem 2005;51:1637–49.
 24. Harmening DM. Modern blood banking and transfusion 
practices. Philadelphia, PA: FA Davis, 2012.
 25. Daniels G, Bromilow I. Essential guide to blood groups. 
Hoboken, NJ: John Wiley & Sons, 2011.
 26. Nanu A, Thapliyal R. Blood group gene frequency in a selected 
north Indian population. Indian J Med Res 1997;106:242–6.
 27. Nathalang O, Kuvanont S, Punyaprasiddhi P, Tasaniyanonda 
C, Sriphaisal T. A preliminary study of the distribution of blood 
group systems in Thai blood donors determined by the gel test. 
Southeast Asian J Trop Med Public Health 2001;32:204–7.
 28. Javed A, Maseer A, Nisar A, Khan G, Showkat A. The BO and 
Rh blood groups in Kashmiri population. Indian J Pract Doctor 
2006;3:200–6.
 29. Reid ME, Lomas-Francis C, Olsson ML. The blood group 
antigen factsbook. Cambridge, MA: Academic Press, 2012.
 30. Chandanayingyong D, Bejrachandra S, Metaseta P, 
Pongsataporn S. Further study of Rh, Kell, Duffy, P, MN, 
Lewis and Gerbiech blood groups of the Thais. Southeast Asian 
J Trop Med Public Health 1979;10:209–11.
 31. Langhi DM Jr, Bordin JO. Duffy blood group and malaria. 
Hematology 2006;11:389–98.
 32. Cleghorn T. MNSs gene frequencies in English blood donors. 
Nature 1960;187:701.
 33. Race RR, Sanger R. Blood groups in man. Oxford: Blackwell 
Scientific Publications, 1965.
 34. Musa RH, Ahmed SA, Hashim H, Ayob Y, Asidin NH, Choo PY, 
et al. Red cell phenotyping of blood from donors at the National 
Blood Center of Malaysia. Asian J Transfus Sci 2012;6:3.
 35. Panigrahi I, Marwaha RK. Common queries in thalassemia 
care. Indian Pediatr 2006;43:513.
 36. Daniels G. Human blood groups. Hoboken, NJ: John Wiley & 
Sons, 2008.
Ehsan Shahverdi, MD, member of Student Research Committee, 
Baqiyatallah University of Medical Sciences, Blood Transfusion 
Research Center, High Institute for Research and Education in 
Transfusion Medicine, Tehran, Iran; Mostafa Moghaddam, MSc 
(corresponding author), Head of Immunohematology Reference 
Laboratory, Iranian Blood Transfusion Organization, Blood 
Transfusion Research Center, High Institute for Research Center 
and Education in Transfusion Medicine, Iranian Blood Transfusion 
Organization Bldg., Hemmat Expy., Tehran, Iran, m.moghaddam@
ibto.ir; Ali Talebian, MD, past Deputy of Technical and Modern 
Technology (retired), Iranian Blood Transfusion Organization, 
Blood Transfusion Research Center, High Institute for Research 
Center and Education in Transfusion Medicine, Tehran, Iran; and 
Hassan Abolghasemi, MD, past Managing Director, Iranian Blood 
Transfusion Organization, current Head of Pediatric Hematology 
and Oncology Department, Baqiyatallah University of Medical 
Sciences, Tehran, Iran.
Attention:  
State Blood Bank Meeting Organizers
If you are planning a state meeting and would like copies of 
Immunohematology for distribution, please send a request, 
4 months in advance, to immuno@redcross.org.
Notice to Readers
All articles published, including communications and  
book reviews, reflect the opinions of the authors and do 
not necessarily reflect the official policy of the American 
Red Cross.
